Novadigm Therapeutics Careers, Jobs, and Salary Information

Novadigm Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate, NDGM-101, is a first-in-class immunotherapy that targets a novel immune checkpoint receptor, VISTA, which is expressed on both tumor cells and immune cells. The company is also developing a pipeline of other immunotherapies targeting various cancers and indications. Novadigm Therapeutics was founded in 2017 and is headquartered in Waltham, Massachusetts.